Medically reviewed by Smita Patel, DO Migraine headaches are predominantly classified as either migraine without aura or ...

June is National Migraine and Headache Awareness Month, a time to raise awareness about the impact of migraine and other ...

The FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and ...

Late-onset migraine aura after age 50 may present without classic headache symptoms, raising diagnostic challenges. A new ...

Brekiya consists of dihydroergotamine mesylate, an ergotamine derivative, in a single-dose autoinjector for subcutaneous administration.

Research shows 65% of migraine patients experience nausea. Discover 5 treatments that provide relief during attacks.

Whether it's one or two coffees to get us going in the morning or a bar of chocolate after a stressful day, many of us ...

Migraine is far more than “just a headache.” It’s a complex neurological disorder that affects nearly one in seven people ...

A doctor has claimed that women who are on the combined pill are 'roughly 28 times' more at risk of experiencing a stroke if ...

Among patients with migraine, evening chronotype is associated with worse physical and mental health outcomes and greater headache-related disability.